Trials / Unknown
UnknownNCT04890431
Impact of Oxygen Therapy on Fatigue in Patients With Hypermobile-type Ehlers-Danlos Syndrome
Impact of Oxygen Therapy on Fatigue in Patients With Hypermobile-type Ehlers-Danlos Syndrome: a Randomised Double-blind Placebo-controlled Study
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 82 (estimated)
- Sponsor
- Hospital St. Joseph, Marseille, France · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The hypothesis of the OXYSED study is that the delivery of 3 months of oxygen therapy via an oxygen concentrator would reduce fatigue, pain, headaches, kinesiophobia, drug intake, dyspnea, and improve walking performance, quality of sleep and quality of life of patients with Ehlers Danlos syndrome hypermobility type (EDS / HT).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Oxygen | oxygen treatment (5 L/minute for 30 minutes by nasal cannula, twice/day) |
| DRUG | Placebo | ambient air not enriched with oxygen (5 L/minute for 30 minutes by nasal cannula, twice/day) |
Timeline
- Start date
- 2022-03-10
- Primary completion
- 2023-10-01
- Completion
- 2024-01-01
- First posted
- 2021-05-18
- Last updated
- 2022-03-31
Locations
3 sites across 1 country: France
Source: ClinicalTrials.gov record NCT04890431. Inclusion in this directory is not an endorsement.